<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for VNDA</title>
    <link />
    <description>Headlines for Vanda Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Top Performing Industries For May 17, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3600128/top-performing-industries-for-may-17-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 17 May 2013 10:35:50 GMT</pubDate>
    </item>
    <item>
      <title>Morning Market Movers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3599989/morning-market-movers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 17 May 2013 09:59:20 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3583570/stocks-hitting-52-week-highs.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 13 May 2013 11:02:35 GMT</pubDate>
    </item>
    <item>
      <title>Vanda Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1421021-vanda-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 16:40:11 GMT</pubDate>
    </item>
    <item>
      <title>Why Did Vanda Pharmaceuticals Hit A 52-Week High?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1353551-why-did-vanda-pharmaceuticals-hit-a-52-week-high.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 19 Apr 2013 02:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Vanda Pharmaceuticals Names Dr. Paolo Baroldi CMO</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3506335/vanda-pharmaceuticals-names-dr-paolo-baroldi-cmo.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 17 Apr 2013 19:40:42 GMT</pubDate>
    </item>
    <item>
      <title>Avoid This Biotech Stock</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/15/avoid-this-biotech-stock/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 15 Mar 2013 09:56:00 GMT</pubDate>
    </item>
    <item>
      <title>Vanda Withdraws Its Marketing Authorization Application For Fanaptum In The European Union</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3418062/vanda-withdraws-its-marketing-authorization-application-for-fanaptum-in-the-europ.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 14 Mar 2013 16:07:35 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Piper Jaffray Initiates Vanda Pharmaceuticals with Overweight on Tasi' Potential</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3394292/update-piper-jaffray-initiates-vanda-pharmaceuticals-wit.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 06 Mar 2013 08:50:47 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Upgrades Vanda Pharmaceuticals to Buy on Tasimelteon Catalyst</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3334008/update-jefferies-upgrades-vanda-pharmaceuticals-to-buy-o.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 14 Feb 2013 07:55:59 GMT</pubDate>
    </item>
    <item>
      <title>Vanda Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1175601-vanda-pharmaceuticals-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 12 Feb 2013 14:40:13 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/02/this-week-in-biotech-13/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 02 Feb 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Vanda Drug Fails in Depression Study</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/01/vanda-drug-fails-in-depression-study/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 01 Feb 2013 11:46:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech: Part 1</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/26/this-week-in-biotech-part-1/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 26 Jan 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>As The Cash Burn At Vanda Pharmaceuticals Intensifies, All Eyes Are Now On The FDA</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1134671-as-the-cash-burn-at-vanda-pharmaceuticals-intensifies-all-eyes-are-now-on-the-fda.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 25 Jan 2013 15:46:08 GMT</pubDate>
    </item>
    <item>
      <title>A Peek Into The Market Before The Trading Starts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3265654/a-peek-into-the-market-before-the-trading-starts.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 23 Jan 2013 07:13:35 GMT</pubDate>
    </item>
    <item>
      <title>Vanda Announces Positive Phase III Study Results for Tasimelteon for Treatment of Non-24-Hour Disord</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/01/3265519/vanda-announces-positive-phase-iii-study-results-for-tasimelteon-for-tre.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 23 Jan 2013 06:45:55 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Initiations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/01/3251566/benzingas-top-initiations.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 17 Jan 2013 07:50:03 GMT</pubDate>
    </item>
    <item>
      <title>Stock Watch Wednesday, 19 December</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1072781-stock-watch-wednesday-19-december.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 19 Dec 2012 09:24:10 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Small Cap Movers for Tuesday December 18, 2012</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/12/12/3184856/benzingas-small-cap-movers-for-tuesday-december-18-2012.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 18 Dec 2012 22:20:20 GMT</pubDate>
    </item>
  </channel>
</rss>
